alexa Medicines Regulation In Australia And New Zealand - Unique And Changing; An Industry Perspective | 13762
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Pharmaceutical Regulatory Affairs

John L. Miller
ScientificTracks Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.010
Abstract
Since 1991 dietary supplements/traditional medicines have been regulated in Australia as medicines - complementary medicines. Consumer surveys have consistently shown that 75% of Australiansuse complementary medicines.Itseems that Australian consumers have a high level of confidence in the supplements they are taking - but has Australia got the right balance in its Regulations? Complementary medicines are governed by the same Australian legislation as orthodox medicines, with the same objective of controlling the supply of quality, safe and efficacious products. The regulatory framework for complementary medicines is based on a risk management approach, designed to ensure public health and safety, while at the same time freeing industry fromunnecessary regulatory burdens. All therapeutic goods must be entered on a Register before they can be supplied in Australia. The Register is a database of information about therapeutic goods for human use approved for supply within, or exported from, Australia. In June 2011, the Prime Ministers of Australia and New Zealand reaffirmed their commitment to the establishment of the Australia New Zealand Therapeutic Products Agency (ANZTPA) to administer a joint regulatory scheme for therapeutic products. This reaffirmation acknowledged that the New Zealand Government will introduce a separate scheme to regulate certain natural health products in the New Zealand market. ANZTPA will establish a single entry point for industry and a common trans-Tasman regulatory framework. In the first stageeach country will retain its own regulator and continue to make its own regulatory decisions, however the industrywill benefit from having only one set of requirements to operate in two countries. The creation of the new regulatory framework will further increase the public health benefit for consumers and reduce the regulatory burden for industry.
Biography
John L. Miller has over 35 years experience in the Complementary/ Pharmaceutical medicines industry. He has wide experience in the regulation, advertising, formulation and manufacture of medicines and foods, within Australia, New Zealand and internationally. He is a longstanding member of the Therapeutic Goods Administration / Industry interface committee which considers technical and regulatory issues influencing the regulation of complementary medicines in Australia. He also chairs various Industry Association committees dealing with GMP, advertising and technical standards. Additionally, he is the founding Chair of MediQ - an initiative of the Queensland medicines industry which is supported by the Queensland Government. This forum drives strategic development and research opportunities building networks between researchers, academics, industry and Government.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7